Jodie P. Morrison
Jodie is CEO of Q32 Bio and was previously a venture partner and CEO of Cadent Therapeutics until its sale to Novartis in 2020. Previously she served as interim CEO
Jodie is CEO of Q32 Bio and was previously a venture partner and CEO of Cadent Therapeutics until its sale to Novartis in 2020. Previously she served as interim CEO